page header

Contents  ·  Introduction  ·  Learning  Objectives  ·  Textbook  ·  Lectures  ·  Procedures  ·  Final Exam  ·  Library  ·  Laboratory  ·  Pharmacy  ·  Imaging  ·  Forms  ·  Videos  ·  About  ·  Contact Us>

Enflurane (Entrane)

Category:

  • General anesthetic

Description:

  • Halogenated, inhalation anesthetic

Indications:

  • General anesthesia

  • Obstetric anesthesia

Contraindications:

  • Malignant hyperthermia

  • Hepatic disease, head trauma, increased intracranial pressure

Precautions:

  • Pregnancy category B; may cause stillbirths

  • Elderly

  • Myasthenia gravis

  • Children

Adverse Reactions (Side Effects):

  • carboxymethemoglobinemia, delirium

  • fetal abortion, fetal stillbirth, neonatal respiratory depression, teratogenesis

  • hepatic necrosis, jaundice, tremor, PVC’s

  • restlessness, nausea, vomiting

Dosage:

Solely for inhalation administration and should only be given by individuals trained in the administration of general anesthetics.  Inhaled anesthetics must be individualized according to surgical requirements, patient variables (age, physical condition, etc.), and use of adjunctive agents such as nitrous oxide

  • General anesthesia induction: 

    • INH: Adult: begin at 0.5% and increase by 0.5% every few breaths

    • Do not exceed 4.5%

    • Maintenance 0.5%-3%

  • Child: 

    • dosage must be individually determined

  • Supplemental obstetric anesthesia (caesarian section): 

    • Adult: 

      • INH 0.5%-1%

  • Supplemental obstetric anesthesia (vaginal delivery):

    • Adult: 

      • INH 0.25%-1%

Drug interactions:

  • Beta-blockers

  •  Aminoglycosides

  •  Antihypertensive agents

  •  Cholinesterase inhibitors

  •  Neuromuscular blockers

  •  Oxytocics

  •  Sympathomimetics

 


The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks

Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300

This information is provided by The Brookside Associates.  The Brookside Associates, LLC. is a private organization, not affiliated with any governmental agency. The opinions presented here are those of the author and do not necessarily represent the opinions of the Brookside Associates or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. All material presented here is unclassified.

C. 2009, 2014, All Rights Reserved

brookside associates logo

 

 

 

 

 

 

Advertise on this site